Entera Bio Ltd (ENTX)

$1.98 0.02 (1.00%)

16:00 EDT ENTX Stock Quote Delayed 30 Minutes

Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024?

By Matthew Farley, InvestorPlace Contributor Apr 15, 2024

Discover three biotech stocks with explosive growth potential. Don't miss out on these great picks this year.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

7 Biotech Penny Stocks With Huge Catalysts Coming in 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 118,877

Day's Range $1.91 - $2.03

52-Week Range $0.52 - $3.35

Dividend & Yield N/A (N/A)

ENTX Stock Predictions, Articles, and Entera Bio Ltd News

From InvestorPlace
From the Web

ENTX Stock: The Huge FDA News Sending Entera Bio Soaring

By Chris MacDonald, InvestorPlace Contributor Jun 23, 2021

Today, investors in ENTX stock are seeing gains of approximately 40% as the company announced results from one of its clinical trials.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Jun 21, 2021

Welcome back and let's get ready to for another busy week of trading. Join us as we look at the biggest pre-market stock movers for Monday!

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Wednesday Morning

By William White, InvestorPlace Writer Apr 7, 2021

We're only halfway through the week but there's plenty of pre-market movers that investors will want to keep an eye on today.

Halted Stocks: What to Know as ENTX Stock Faces Trading Halts

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Mar 12, 2021

ENTX stock continues to sky rocket, leading investors to question halted stocks. Here's what you should know now.

ENTX Stock: 11 Things for Entera Bio Investors to Know as Shares Blast 200%+ Higher

By William White, InvestorPlace Writer Mar 11, 2021

Entera Bio (ENTX) stock is soaring higher on Thursday following an update from the biotech company about its osteoporosis treatment.

Entera Bio files to sell 16.5M ordinary shares for holders (NASDAQ:ENTX)

From Seeking Alpha Feb 2, 2024

Learn about Entera Bio's recent filing of a prospectus for the offer and resale of up to 16,500,894 shares of its ordinary shares by selling shareholders.

Amgen, Entera end research collaboration (NASDAQ:ENTX)

From Seeking Alpha May 8, 2023

Amgen (AMGN) and Israeli biopharma Entera Bio (ENTX) are ending a research collaboration that began in 2018. Read more here.

H.C. Wainwright Remains a Buy on Entera Bio (ENTX)

From TipRanks Nov 14, 2022

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Entera Bio (ENTX – Research Report) today and set a price target of $10.00. The company&#8217...

Analysts Offer Insights on Healthcare Companies: Entera Bio (ENTX) and Quoin Pharmaceuticals (QNRX)

From TipRanks Nov 12, 2022

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Entera Bio (

Entera Bio (ENTX) Receives a Buy from H.C. Wainwright

From TipRanks Oct 11, 2022

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Entera Bio (ENTX – Research Report) yesterday and set a price target of $10.00. The company&#...

Analysts’ Top Healthcare Picks: InflaRx (IFRX), Entera Bio (ENTX)

From TipRanks Sep 29, 2022

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on InflaRx (

ADVERTISEMENT